To determine whether HSP90 increases the PUS7 levels in CRC cells via the modulating of protein stability, the cycloheximide (CHX, a protein synthesis inhibitor) chase assay was employed. This evidence concerns the gene HSP90AB1 and colorectal carcinoma.